PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Although aging is a known risk factor for idiopathic pulmonary fibrosis (IPF), the pathogenic mechanisms that underlie the effects of advancing age remain largely unexplained. Some age-related neurodegenerative diseases have an etiology that is related to mitochondrial dysfunction. Here, we found that alveolar type II cells (AECIIs) in the lungs of IPF patients exhibit marked accumulation of dysmorphic and dysfunctional mitochondria. These mitochondrial abnormalities in AECIIs of IPF lungs were associated with upregulation of ER stress markers and were recapitulated in normal mice with advancing age in response to stimulation of ER stress. We found that impaired mitochondria in IPF and aging lungs were associated with low expression of PTEN-induced putative kinase 1 (PINK1). Knockdown of PINK1 expression in lung epithelial cells resulted in mitochondria depolarization and expression of profibrotic factors. Moreover, young PINK1-deficient mice developed similarly dysmorphic, dysfunctional mitochondria in the AECIIs and were vulnerable to apoptosis and development of lung fibrosis. Our data indicate that PINK1 deficiency results in swollen, dysfunctional mitochondria and defective mitophagy, and promotes fibrosis in the aging lung.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, the levels of PINK1 decline with age, suggesting that a time‐dependent drop in mitophagy proficiency may contribute to the development of pulmonary fibrosis in aged individuals (Bueno et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Bueno et al, 2015
In the citing paper
“| Pulmonary fibrosis | Whole‐body deletion of Pink1 | Accelerated development of bleomycin‐induced lung fibrosis linked to accumulation of dysfunctional mitochondria in AEC cells | Bueno et al (2015) |”
From Autophagy in major human diseases (2021) · cites this paper as Bueno et al (2015)
In the citing paper
“Of note, the levels of PINK1 decline with age, suggesting that a time‐dependent drop in mitophagy proficiency may contribute to the development of pulmonary fibrosis in aged individuals (Bueno et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Bueno et al, 2015
In the citing paper
“In accordance with this notion, genetic loss of Pink1 and Prkn accelerates the development of the fibrotic phenotype in bleomycin‐treated mice, linked to alveolar epithelial cell II (AECII) loss and accrued inflammation (Bueno et al, 2015; Kobayashi et al, 2016).”
From Autophagy in major human diseases (2021) · cites this paper as Bueno et al, 2015
In the citing paper
“Pink1 deficiency leads to mitochondrial damage and hence promotes lung fibrosis (56), whereas a decreased expression of mitochondrial fission proteins Drp1 and mitochondrial fission 1 protein induces cellular senescence via a Pink1-dependent manner (57).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [56]
Citations
Cites
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812 · cited 1×
“Mitochondrial materials such as mtDNA that leak from damaged mitochondria have been reported to elucidate inflammatory responses (48, 49).”
BackgroundHereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Youle, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
Clinical course and prediction of survival in idiopathic pulmonary fibrosis
Ley, B., Collard, H. R., & King, T. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0894ci · Cited by 1,765 · cited 1×
“The median age of diagnosis of IPF is approximately 66 years (4, 5).”
BackgroundTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 1×
“Whereas the familial disease has been related to mutations in surfactant proteins and telomerase, the cause of the majority of sporadic IPF cases and the mechanisms involved in aging-related IPF susceptibility are still unknown (6, 7).”
BackgroundIncidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310
Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure
Oka, T., Hikoso, S., Yamaguchi, O., Taneike, M., Takeda, T., Tamai, T., Oyabu, J., Murakawa, T., Nakayama, H., Nishida, K., et al. (2012) · Nature · doi:10.1038/nature10992 · Cited by 1,201
The role of mitochondria in aging
Bratic, A., & Larsson, N.-G. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64125 · Cited by 1,087 · cited 1×
“Abnormalities in mitochondria are often observed with aging, including enlargement, loss of cristae, destruction of inner membranes, swelling, and impaired respiration (12).”
BackgroundDagda, R. K., Cherra, S. J., Kulich, S. M., Tandon, A., Park, D., & Chu, C. T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808515200 · Cited by 954
Self-citation
Research works printed but not linked: 2
- Crapo, 1978, Lab Invest., 39, 640
- Malhotra, 2011, Cold Spring Harb Perspect Biol., 3, a004424
Cited by
Items 601–624 of 624
Alveolar Epithelial Cell Loss of the Mitochondrial Regulator TFAM Drives Progressive Lung FibrosisPreprint
Hu, Q., Onwuka, U., Cárdenes, N., Packwood, M., Huang, E. L., Shi, J., Melo-Narváez, M. C., Dutta, P., Zhou, Z., Beaulieu, D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.28.728065
“…alveolar epithelial cellular properties, while defective mitophagy, impaired fatty acid oxidation, altered epithelial redox control, and mitochondrial complex I dysfunction can compromise AT2 cell repair, promote aberrant epithelial states, and increase fibrosis susceptibility (18, 30-32, 62, 63).”
Self-citationChen, L., Hu, S., Tang, X., Wang, Y., Zou, Y., Luo, F., & Wan, H. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1740661
“Notably, the accumulation of enlarged fused mitochondria and dysregulated mitophagy were identified to be hallmarks of AT2 aging, associating with impaired regenerative capacity and surfactant homeostasis (Bueno et al., 2015; Mora et al., 2017).”
Tan, X., Zhang, J., Yang, Q., Zhu, K., Hou, Y. Y., Guo, Z., Li, X., Deng, H., Chen, C., Deng, C., et al. (2026) · Cell & Bioscience · doi:10.1186/s13578-026-01600-4
“Moreover, deficiency of PINK1, a key regulator of mitophagy, impairs mitochondrial homeostasis, thereby promoting apoptosis of alveolar epithelial cells and contributing to the progression of pulmonary fibrosis [62].”
Mitochondrial dysfunction in pulmonary fibrosis: from mechanisms to therapeutic opportunities
Jin, X., Sang, L., Zhu, J., Zhong, Z., & Sun, J. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118164
Li, C., Wang, L., Wang, F., Wang, L., Xu, L. H., Lyu, W., Shan, K., Li, J., Zhou, H., Rong, F., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03921-0
“This drives sustained activation of fibroblasts and the release of low-grade inflammatory mediators [23, 24, 86, 132–137] (Fig.”
Lin, J., Pan, Z., Sun, J., Wang, X., Zhang, L., Ye, Y., Yin, D. P., Wang, Y., & Guo, Q. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1844269
“This procedure aimed to determine the ratio of mitochondrial DNA (mtDNA) to nuclear DNA (nDNA) as well as the mtDNA copy number according to previous researches (Quiros et al., 2017; Bueno et al., 2015).”
Mitoception: A Novel Strategy to Alleviate Pulmonary Fibrosis
Bhogoju, S., Patel, P., Kapur, N., Kunjadia, P. D., Aloysius, A., Esoe, D.-P. I., Sturgill, J., Brainson, C. F., Chaiswing, L., Sullivan, P. G., et al. (2026) · Biology · doi:10.3390/biology15141112
BAIBA attenuates pulmonary fibrosis by modulating the iron/ROS–mitochondrion–apoptosis cascade
Du, C., Wang, J., Wang, X., Tan, K., Wang, B., Chen, J., Luo, B., Xiong, Z., Zhang, Z., Liu, S., et al. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.07.029
Breaking barriers in pulmonary health of patients with metabolic diseases: senolytics and beyond
Rennerova, M., Žaloudíková, M., Haluzík, M., & Hubáčková, S. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1812724 · Cited by 1
“Persistent metabolic dysregulation can further promote mitochondrial dysfunction and activation of profibrotic signaling pathways, thereby facilitating pulmonary fibrotic remodeling (Bueno et al., 2015).”
Weston, M. S., Domínguez-Prieto, M., & Moisoi, N. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112763
Endothelial cell–pericyte interactions in ischemic stroke: From microvascular pathology to repair
Feng, S., Zhang, C., Zhao, Y., Wang, Y., 张柏民, Zhang, Q., Zheng, Y., Cheng, F., Li, C., Wang, X., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108351
Levothyroxine dry powder for inhalation: spray drying or micronization?
Bazzoli, G., Bianchera, A., & Bettini, R. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108772
Liu, C., 杨蓝楠, Yang, J., Wang, J., Zhao, J., Ding, X., & Ni, Q. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1867680
Yoshida, M., & Araya, J. (2026) · European Respiratory Review · doi:10.1183/16000617.0278-2025
“IPF AT2 cells show abnormally swollen mitochondria with disrupted ultrastructure, associated with low levels of the mitophagy regulators PINK1 and PARK2 (Parkin) [14].”
Nathwani, V., Weeratunga, P., Woo, J., Denney, L., Vuppusetty, C., Hu, T. H., Zulfikar, S., Achaiah, A., Baghaarabani, L., Parker, H., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117881
Parolin, C., Gentile, E., Pellegrino, C., Spada, V., Bassi, C., Sabbioni, S., Vitali, B., Pinton, P., & Rimessi, A. (2026) · Biomedicines · doi:10.3390/biomedicines14091965
“Reported abnormalities include mitochondrial ROS accumulation, impaired mitophagy, altered mitochondrial biogenesis, metabolic reprogramming, and reduced stress tolerance [133,150,151].”
Bärnthaler, T., Ding, S., Adams, T. S., Rose, K.-A., Rangel, R., Khoury, J., Salimi, M., Anderson, S., Lin, L., Velasco-Alzate, K. Y., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.31.747360
Mitophagy in idiopathic pulmonary fibrosis: from molecular mechanisms to therapeutic opportunities
He, M., Li, Y., Huang, H., Cong, Z., & Yang, Y. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1925197
“However, excessive or sustained ERS may suppress Parkin expression, leading to defective mitophagy and establishing a vicious cycle of ERS–mitochondrial dysfunction (Bueno et al., 2015).”
InfluentialLi, X., Fu, Z., Sun, D., Jin, Z., & Jiao, H. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112258 · Cited by 1
Fuelling repair: metabolic regulation of alveolar type 2 cell fate in lung regeneration and disease
Wugk, S., Kenny, S., Masood, F., Htoo, E. T., & Cloonan, S. M. (2026) · Disease Models & Mechanisms · doi:10.1242/dmm.052978
“Mitochondrial damage is also associated with dysregulated lipid metabolism, including disrupted FAS and Newton et al., 2021; Rodríguez et al., 2025 Bueno et al., 2015; Patel et al., 2015; Chung et al., 2019; He et al., 2026 Shao et al., 2024 Chung et al., 2019; Liang et al., 2024; Yang et al.,…”
Yang, L., Huang, Y., Liu, A., Yan, Y., Liu, B., & Yuan, X. (2026) · Biomedicines · doi:10.3390/biomedicines14102265
Luo, L., Li, Y., & Shifang, H. (2026) · CytoJournal · doi:10.25259/cytojournal_171_2026
Zhang, Q., Yang, H., Hu, C., Zhang, C., & He, L. (2026) · Microscopy Research and Technique · doi:10.1002/jemt.70192
Metabolic reprogramming in pulmonary fibrosis: mechanisms and therapeutic perspectives
Wu, Y., Su, X., Zhou, J., Zheng, S., 冯琼, 庄静英, Yu, Z., Qiu, H., Xia, Y., Wu, J., et al. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1982119
“The PINK1/Parkin-mediated mitochondrial autophagy pathway plays a key role in this process (65), while IL-17A induces mitochondrial dysfunction in alveolar type II epithelial cells by inhibiting PINK1-mediated mitochondrial autophagy, thereby exerting its pro-fibrotic effect (66).”
Metadata
- Authors
- Bueno, M., Lai, Y.-C., Romero, Y., Brands, J., St. Croix, C. M., Kamga, C., Corey, C., Herazo-Maya, J. D., Sembrat, J., Lee, J. S., Duncan, S. R., Rojas, M., Shiva, S., Chu, C. T., & Mora, A. L.
- Affiliations
- University of Pittsburgh (US)
- Universidad Nacional Autónoma de México (MX)
- Corresponding author
- Mora, Ana L.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-12-22
- Volume
- 125
- Issue
- 2
- Pages
- 521-538
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4319413
- OpenAlex
- W2054760729
- Cited by
- 627
- References
- 65
- Citations by year
- 2026: 50 · 2025: 63 · 2024: 74 · 2023: 63 · 2022: 49 · 2021: 68 · 2020: 59 · 2019: 57 · 2018: 49 · 2017: 42 · 2016: 33 · 2015: 18
- FWCI
- 24.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pittsburgh
- Hemophilia Center of Western Pennsylvania
- National Institutes of Health (DK072506, NS065789)
- National Institute on Aging (AG026389, R01AG026389)
- National Heart, Lung, and Blood Institute (R01HL086884, R01HL123766)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK072506)
- National Institute of Neurological Disorders and Stroke (NS065789, R01NS065789, R56NS065789)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- PINK1, idiopathic pulmonary fibrosis, lung aging, mitochondrial dysfunction, alveolar type II cells, endoplasmic reticulum stress, mitophagy, mitochondrial depolarization, apoptosis, mitochondrial homeostasis
- MeSH terms
- PTEN-Induced Putative Kinase, Aging, Animals, Humans, Mice, Inbred BALB C, Mitochondria, Protein Kinases, Pulmonary Alveoli, Up-Regulation, Apoptosis, Mice, Knockout, Cell Line, Tumor, Mice, Idiopathic Pulmonary Fibrosis, Endoplasmic Reticulum Stress, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.